Skip to main content
Top
Published in: Clinical and Experimental Nephrology 7/2021

01-07-2021 | Hyperglycemia | Original article

Prevalence and determinants of chronic kidney disease in urban adults’ populations of northern Cameroon

Authors: Francois Folefack Kaze, Mahamat Maimouna, Augustin Fanday Beybey, Eric Walter Pefura-Yone, Adamou Dodo Balkissou, Marie Patrice Halle, Mathurin Pierre Kowo, Gloria Ashuntantang, Andre-Pascal Kengne

Published in: Clinical and Experimental Nephrology | Issue 7/2021

Login to get access

Abstract

Background

Chronic kidney disease (CKD) is a major health problem with growing prevalence in sub-Saharan Africa.

Aim

Assess the prevalence and determinants of CKD in Garoua and Figuil cities of the North region of Cameroon.

Methods

A cross-sectional survey was conducted from January to June 2018 in the two cities, using a multi-level cluster sampling. All adults with low estimated glomerular filtration rate (eGFR) (< 60 ml/min/1.73 m2) by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and/or albuminuria (≥ 30 mg/g) were reviewed three months later. Logistic regression models (accounting for the sampling strategy) were used to investigate the predictors of the outcomes.

Results

A total of 433 participants were included, with a mean age (95%CI) of 45.0 (43.4–46.6) years, 212 (48.7%) men, 294 (67.9%) from Garoua and 218 (45.6%) with no formal education. Risk factors for chronic nephropathy were highly prevalent including longstanding use of street medications (52.8%), herbal medicines (50.2%) and non-steroidal anti-inflammatory drugs (50%), alcohol consumption (34.4%), hypertension (33.9%), overweight/obesity (33.6%), hyperuricemia (16.8%), smoking (11.3%) and hyperglycemia (6.5%). The prevalence of CKD was 11.7% overall, 10.7% in Garoua and 13% in Figuil participants. Equivalents figures for CKD G3-5 and albuminuria were 2.8%, 2.0% and 4.5%; and 9.1%, 9.3% and 8.5%, respectively. History of diabetes, increase systolic blood pressure, hyperglycemia and hyperuricemia were predictors of CKD.

Conclusion

The prevalence of CKD is as high in these northern cities as previously reported in southern cities of Cameroon, driven mostly by known modifiable risk factors of chronic nephropathy.
Literature
2.
go back to reference Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, Hobbs FD. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS ONE. 2016;11(7):e0158765.CrossRef Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, Hobbs FD. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS ONE. 2016;11(7):e0158765.CrossRef
3.
go back to reference Kaze AD, Ilori T, Jaar BG, Echouffo-Tcheugui JB. Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis. BMC Nephrol. 2018;19(1):125.CrossRef Kaze AD, Ilori T, Jaar BG, Echouffo-Tcheugui JB. Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis. BMC Nephrol. 2018;19(1):125.CrossRef
4.
go back to reference Kaze FF, Kengne AP, Magatsing CT, Halle MP, Yiagnigni E, Ngu KB. Prevalence and determinants of chronic kidney disease among hypertensive cameroonians according to three common estimators of the glomerular filtration rate. J Clin Hypertens (Greenwich). 2016;18(5):408–14.CrossRef Kaze FF, Kengne AP, Magatsing CT, Halle MP, Yiagnigni E, Ngu KB. Prevalence and determinants of chronic kidney disease among hypertensive cameroonians according to three common estimators of the glomerular filtration rate. J Clin Hypertens (Greenwich). 2016;18(5):408–14.CrossRef
5.
go back to reference Hamadou B, Boombhi J, Kamdem F, Fitame A, Amougou SN, Mfeukeu LK, Nganou CN, Menanga A, Ashuntantang G. Prevalence and correlates of chronic kidney disease in a group of patients with hypertension in the Savanah zone of Cameroon: a cross-sectional study in Sub-Saharan Africa. Cardiovasc Diagn Ther. 2017;7(6):581–8.CrossRef Hamadou B, Boombhi J, Kamdem F, Fitame A, Amougou SN, Mfeukeu LK, Nganou CN, Menanga A, Ashuntantang G. Prevalence and correlates of chronic kidney disease in a group of patients with hypertension in the Savanah zone of Cameroon: a cross-sectional study in Sub-Saharan Africa. Cardiovasc Diagn Ther. 2017;7(6):581–8.CrossRef
6.
go back to reference FolefackKaze F, Kengne AP, Pefura Yone EW, NdamFemben NS, Ashuntantang G. Renal function, urinalysis abnormalities and correlates among HIV-infected Cameroonians naive to antiretroviral therapy. Saudi J Kidney Dis Transpl. 2013;24(6):1291–7.CrossRef FolefackKaze F, Kengne AP, Pefura Yone EW, NdamFemben NS, Ashuntantang G. Renal function, urinalysis abnormalities and correlates among HIV-infected Cameroonians naive to antiretroviral therapy. Saudi J Kidney Dis Transpl. 2013;24(6):1291–7.CrossRef
7.
go back to reference Kaze FF, Kengne AP, Atanga LC, Monny Lobe M, Menanga AP, Halle MP, Chetcha Chemegni B, Ngo Sack F, Kingue S, Ashuntantang G. Kidney function, urinalysis abnormalities and correlates in equatorial Africans with sickle cell disease. Clinical Kidney J. 2012;6(1):15–20.CrossRef Kaze FF, Kengne AP, Atanga LC, Monny Lobe M, Menanga AP, Halle MP, Chetcha Chemegni B, Ngo Sack F, Kingue S, Ashuntantang G. Kidney function, urinalysis abnormalities and correlates in equatorial Africans with sickle cell disease. Clinical Kidney J. 2012;6(1):15–20.CrossRef
8.
go back to reference Sumaili EK, Cohen EP, Zinga CV, Krzesinski JM, Pakasa NM, Nseka NM. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol. 2009;10:18.CrossRef Sumaili EK, Cohen EP, Zinga CV, Krzesinski JM, Pakasa NM, Nseka NM. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol. 2009;10:18.CrossRef
9.
go back to reference Anand S, Bitton A, Gaziano T. The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS ONE. 2013;8(8):e72860.CrossRef Anand S, Bitton A, Gaziano T. The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS ONE. 2013;8(8):e72860.CrossRef
10.
go back to reference Ashuntantang G, Osafo C, Olowu WA, Arogundade F, Niang A, Porter J, Naicker S, Luyckx VA. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Glob Health. 2017;5(4):e408–17.CrossRef Ashuntantang G, Osafo C, Olowu WA, Arogundade F, Niang A, Porter J, Naicker S, Luyckx VA. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Glob Health. 2017;5(4):e408–17.CrossRef
11.
go back to reference Kaze FF, Halle MP, Mopa HT, Ashuntantang G, Fouda H, Ngogang J, Kengne AP. Prevalence and risk factors of chronic kidney disease in urban adult Cameroonians according to three common estimators of the glomerular filtration rate: a cross-sectional study. BMC Nephrol. 2015;16:96.CrossRef Kaze FF, Halle MP, Mopa HT, Ashuntantang G, Fouda H, Ngogang J, Kengne AP. Prevalence and risk factors of chronic kidney disease in urban adult Cameroonians according to three common estimators of the glomerular filtration rate: a cross-sectional study. BMC Nephrol. 2015;16:96.CrossRef
12.
go back to reference Kaze FF, Meto DT, Halle MP, Ngogang J, Kengne AP. Prevalence and determinants of chronic kidney disease in rural and urban Cameroonians: a cross-sectional study. BMC Nephrol. 2015;16:117.CrossRef Kaze FF, Meto DT, Halle MP, Ngogang J, Kengne AP. Prevalence and determinants of chronic kidney disease in rural and urban Cameroonians: a cross-sectional study. BMC Nephrol. 2015;16:117.CrossRef
13.
go back to reference Sumaili EK, Krzesinski JM, Zinga CV, Cohen EP, Delanaye P, Munyanga SM, Nseka NM. Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant. 2009;24(1):117–22.CrossRef Sumaili EK, Krzesinski JM, Zinga CV, Cohen EP, Delanaye P, Munyanga SM, Nseka NM. Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant. 2009;24(1):117–22.CrossRef
14.
go back to reference Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C, Clark T: 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999, 21(5–6):1009–1060. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C, Clark T: 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999, 21(5–6):1009–1060.
15.
go back to reference Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470–5.CrossRef Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470–5.CrossRef
16.
go back to reference Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28(10):2077–80.CrossRef Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28(10):2077–80.CrossRef
17.
go back to reference Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.CrossRef Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.CrossRef
18.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef
19.
go back to reference Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ 3rd. For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int. 2009;75(10):1071–8.CrossRef Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ 3rd. For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int. 2009;75(10):1071–8.CrossRef
20.
go back to reference K/DIGO Guidelines. Definition and classification. Kidney Int Suppl 2013, 3(1):19–62. K/DIGO Guidelines. Definition and classification. Kidney Int Suppl 2013, 3(1):19–62.
21.
go back to reference Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143–3421. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143–3421.
23.
go back to reference Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP: Burden of Undiagnosed Hypertension in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Hypertension 2014. Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP: Burden of Undiagnosed Hypertension in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Hypertension 2014.
24.
go back to reference Katte JC, Dzudie A, Sobngwi E, Mbong EN, Fetse GT, Kouam CK, Kengne AP. Coincidence of diabetes mellitus and hypertension in a semi-urban Cameroonian population: a cross-sectional study. BMC Public Health. 2014;14:696.CrossRef Katte JC, Dzudie A, Sobngwi E, Mbong EN, Fetse GT, Kouam CK, Kengne AP. Coincidence of diabetes mellitus and hypertension in a semi-urban Cameroonian population: a cross-sectional study. BMC Public Health. 2014;14:696.CrossRef
25.
go back to reference Johnson RJ, Wesseling C, Newman LS. Chronic Kidney Disease of Unknown Cause in Agricultural Communities. N Engl J Med. 2019;380(19):1843–52.CrossRef Johnson RJ, Wesseling C, Newman LS. Chronic Kidney Disease of Unknown Cause in Agricultural Communities. N Engl J Med. 2019;380(19):1843–52.CrossRef
26.
go back to reference Torres C, Aragon A, Gonzalez M, Lopez I, Jakobsson K, Elinder CG, Lundberg I, Wesseling C. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis. 2010;55(3):485–96.CrossRef Torres C, Aragon A, Gonzalez M, Lopez I, Jakobsson K, Elinder CG, Lundberg I, Wesseling C. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis. 2010;55(3):485–96.CrossRef
27.
go back to reference Peraza S, Wesseling C, Aragon A, Leiva R, Garcia-Trabanino RA, Torres C, Jakobsson K, Elinder CG, Hogstedt C. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis. 2012;59(4):531–40.CrossRef Peraza S, Wesseling C, Aragon A, Leiva R, Garcia-Trabanino RA, Torres C, Jakobsson K, Elinder CG, Hogstedt C. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis. 2012;59(4):531–40.CrossRef
28.
go back to reference Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14(6):361–77.CrossRef Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14(6):361–77.CrossRef
29.
go back to reference Anders HJ. 2018 update in basic kidney research: fibrosis, inflammation, glomerular filtration and kidney disease progression. Nephrol Dial Transplant. 2019;34(5):719–23.CrossRef Anders HJ. 2018 update in basic kidney research: fibrosis, inflammation, glomerular filtration and kidney disease progression. Nephrol Dial Transplant. 2019;34(5):719–23.CrossRef
Metadata
Title
Prevalence and determinants of chronic kidney disease in urban adults’ populations of northern Cameroon
Authors
Francois Folefack Kaze
Mahamat Maimouna
Augustin Fanday Beybey
Eric Walter Pefura-Yone
Adamou Dodo Balkissou
Marie Patrice Halle
Mathurin Pierre Kowo
Gloria Ashuntantang
Andre-Pascal Kengne
Publication date
01-07-2021
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 7/2021
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-021-02036-5

Other articles of this Issue 7/2021

Clinical and Experimental Nephrology 7/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.